MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
2.490
+0.050 (2.05%)
At close: Jul 25, 2025, 4:00 PM
2.580
+0.090 (3.61%)
After-hours: Jul 25, 2025, 6:25 PM EDT
MDxHealth Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MDxHealth stock has a target of 6, which predicts a 140.96% increase from the current stock price of 2.49.
Price Target: $6 (+140.96%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 7, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for MDxHealth is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +140.96% | Nov 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +181.12% | Mar 7, 2024 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +221.29% | Mar 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +140.96% | Nov 9, 2023 |
| TD Cowen | TD Cowen | Buy Initiates $7 | Buy | Initiates | $7 | +181.12% | May 31, 2023 |
Financial Forecast
Revenue This Year
111.22M
from 90.05M
Increased by 23.51%
Revenue Next Year
130.88M
from 111.22M
Increased by 17.68%
EPS This Year
-0.49
from -1.16
EPS Next Year
-0.22
from -0.49
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 115.5M | 139.0M | 163.0M | |
| Avg | 111.2M | 130.9M | 153.1M | |
| Low | 106.3M | 122.5M | 142.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 28.3% | 25.0% | 24.5% | |
| Avg | 23.5% | 17.7% | 17.0% | |
| Low | 18.1% | 10.1% | 8.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.35 | -0.02 | 0.05 |
| Avg | -0.49 | -0.22 | 0.03 |
| Low | -0.53 | -0.32 | - |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.